Published in
Taylor and Francis Group, Expert Opinion on Investigational Drugs, 2(21), p. 205-216, 2011
DOI: 10.1517/13543784.2011.641532
Links
Tools
Brentuximab Vedotin (SGN-35), an antibody–drug conjugate for the treatment of CD30-positive malignancies
Journal article published in 2011 by
Antonio Gualberto 
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 